Joslin Researchers Reveal Mechanisms Behind A Class Of Oral Agents Used To Treat Type 2 Diabetes (Medical News Today)
BOSTON " Thiazolidinediones (TZD's) are drugs commonly prescribed to patients with type 2 diabetes, the most common form of diabetes. Current U.S. Food and Drug Administration-approved agents are known as Actos (pioglitazone) and Avandia (rosiglitazone). These oral agents improve blood glucose levels in people with diabetes by improving insulin action in the body... click link for more info.